Viva In Vitro: Funding, Investors & Team (Sep 2026)
By creating revolutionary, nlrp3-based diagnostic and prognostic compact devices that allow hospitals' laboratories and doctors to more quickly and accurately stratify patients with septic shock and other acute inflammatory disorders, we can save lives. The scientific vision of Dr. Pablo Pelegrn Clinical group directed by Dr. Garciano BHV Partners' market research Instituto Murciano de Investigación Biosanitaria (IMIB) offshoot CiDi Salud's Proof of Concept project received funding from the European Research Council.
Viva In Vitro has raised $200k across 1 funding round on record, the most recent a Pre-Seed of $200k announced in Nov 2022.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Viva In Vitro Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Viva In Vitro Funding Rounds
Viva In Vitro Founders and Leadership Team
No contact details are on record for this team yet.
Viva In Vitro Funding Compared to Other Health Care Startups
Viva In Vitro's latest round of $200k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Viva In Vitro in Health Care and El Palmar
Companies Similar to Viva In Vitro
Valentia Foundation supports individuals with intellectual disabilities and Autism Spectrum Disorder (ASD),…
BASE4 Biosciences is a precision health firm developing a new layer of preventive medicine.
Opportunity Health is an innovative Navarrese company
Qida is a company that provides high-quality and compassionate home care for elderly or dependent…
2Eyes Vision, a company based in Madrid and established in 2015 as a spin off from CSIC, is focused on…
Healthy Minds offers business-to-business mental health solutions for companies that are powered by…
Gestcompost is dedicated to managing organic and biodegradable waste.
Ysium Medical provides cutting-edge technological solutions for the future of healthcare.
Geniova, a Spanish start-up, focuses on invisible orthodontics by combining a patented method using a lingual…
CORIFY Care is a start-up funded by main world-wide experts on cardiac arrhythmias which is going to…
Heecap is a non-invasive, tailored electrostimulation technology that maintains respiratory muscle strength…
NeuronUP is a platform that allows professionals to access exercise routines for their patients at any time…
Viva In Vitro Funding FAQs
What does Viva In Vitro do?
By creating revolutionary, nlrp3-based diagnostic and prognostic compact devices that allow hospitals' laboratories and doctors to more quickly and accurately stratify patients with septic shock and other acute inflammatory disorders, we can save lives. The scientific vision of Dr. Pablo Pelegrn Clinical group directed by Dr. Garciano BHV Partners' market research Instituto Murciano de Investigación Biosanitaria (IMIB) offshoot CiDi Salud's Proof of Concept project received funding from the European Research Council.
How much funding has Viva In Vitro raised?
Viva In Vitro has raised $200k across 1 round on record. The most recent is a Pre-Seed of $200k announced in Nov 2022.
When did Viva In Vitro last raise funding?
Viva In Vitro's most recent funding round on record is a Pre-Seed of $200k, announced in Nov 2022.
Who is the CEO of Viva In Vitro?
Joaquin Gomez Moya is listed as CEO at Viva In Vitro.
Where is Viva In Vitro headquartered?
Viva In Vitro is based in El Palmar, Murcia, Spain.
How many employees does Viva In Vitro have?
Viva In Vitro is in the 1-10 employee band.
How does Viva In Vitro's funding compare to other Health Care startups?
Viva In Vitro's latest round of $200k is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Viva In Vitro Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Viva In Vitro is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.